Last updated on October 2020

Efficacy and Safety of Olaparib (MK-7339) in Participants With Previously Treated Homologous Recombination Repair Mutation (HRRm) or Homologous Recombination Deficiency (HRD) Positive Advanced Cancer (MK-7339-002 / LYNK-002)


Find a site near you

Start Over

Clinical Hospital Saint Luka ( Site 1205)

Saint-Petersburg, Russian Federation
  Connect »

UCSF - Mt. Zion Campus ( Site 0007)

San Francisco, CA United States
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.